Peptides for muscle gain: what gym TikTok gets wrong

What did @shanebuildsmuscle actually say?

Shane is promoting a product called the "T10," which he describes as an "oral version" of what he calls a "test peptide" — strongly implying it raises testosterone. He says it's "very strong," that only about 60 units have been sold, and frames scarcity as a feature. He recommends it exclusively to men, and presents being an early adopter as a selling point rather than a warning sign.

To be fair, he's not making outright medical claims in classic supplement-ad language. But the implication is unmistakable: this product mimics or stimulates testosterone. Calling it "the test peptide" and saying it's "pretty self explanatory" is doing a lot of work without technically lying. That's a common pattern in unregulated supplement marketing, and it's worth examining closely.

Does the science back this up?

No peer-reviewed evidence supports an oral peptide that meaningfully raises testosterone in healthy humans. Full stop. The biology here is the problem, not just the lack of data.

Peptides are chains of amino acids. When you swallow them, your digestive system breaks them down into individual amino acids before they reach systemic circulation. This is why legitimate peptide therapies — like GLP-1 agonists or certain growth hormone secretagogues — are typically administered by injection, not orally. A small number of peptides survive oral delivery via specialized formulations (cyclic peptides, nanoparticle encapsulation), but those are the exception and require significant pharmaceutical engineering to achieve even modest bioavailability.

There is no peptide currently recognized in clinical literature that reliably stimulates endogenous testosterone production orally at the doses achievable in a consumer supplement. Luteinizing hormone-releasing hormone (LHRH) analogs exist, but they require injection and are controlled substances. The claim that "T10" is a novel oral testosterone peptide with only 60 units sold is not a marker of exclusivity. It's a marker of no clinical validation whatsoever.

What did they get wrong (or right)?

Shane got the scarcity framing exactly backwards. He says being "one of the first dudes on it" means you're "ahead of the curve." In regulated medicine, being the first 60 people to use an untested compound with no published safety data is not an advantage. It's a risk.

He's also wrong that a testosterone-affecting product "wouldn't" apply to women. The hypothalamic-pituitary-gonadal axis exists in both sexes. Any compound that meaningfully alters testosterone signaling could affect women too, in ways that are not benign. Testosterone dysregulation in women is associated with polycystic ovary syndrome, virilization, and menstrual disruption (Legro et al., 2013, Journal of Clinical Endocrinology and Metabolism). Saying "this isn't for women" without clinical rationale is not a safety disclosure. It's a marketing choice.

What he got right, loosely: the idea that testosterone optimization is a real clinical space. Low testosterone (hypogonadism) is a legitimate medical condition with established treatments. The interest is valid. This specific product, based on available information, is not.

What should you actually know?

If you're interested in testosterone levels, there are evidence-based options. Clinically diagnosed hypogonadism can be treated with FDA-approved testosterone replacement therapy under physician supervision. Lifestyle factors including sleep, resistance training, body fat reduction, and stress management have measurable effects on testosterone in multiple randomized controlled trials (Leproult and Van Cauter, 2011, JAMA; Riachy et al., 2020, Journal of Functional Morphology and Kinesiology).

Unverified oral peptides sold through TikTok with 60 units sold and no published pharmacokinetic data are not a substitute for any of that. The lack of clinical trials is not a temporary gap waiting to be filled. It's a red flag. Products that affect hormone signaling without regulatory oversight carry real risks: endocrine disruption, liver strain from oral androgenic compounds, and interactions with other medications.

FormBlends operates as a regulated telehealth platform for a reason. If you want to explore peptide therapy or testosterone support, that conversation starts with a licensed clinician reviewing your labs, not a TikTok caption that says "level up."